IGM Biosciences (IGMS) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -30.4 | -4.96 | -1.45 | -0.54 | -1.16 | -5.98 | ||
| Changes by years, y/y, % | +920% | -84% | -71% | -63% | +115% | -17.2% | |||
IGM Biosciences. EV/EBITDA
IGM Biosciences. EV/EBITDA, changes, %
IGM Biosciences (IGMS) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| EV/EBITDA | ? | -0.87 | -3.68 | -1.16 | 0.21 | 1.13 | -5.98 | |
| Changes by years, y/y, % | +194% | +498% | +48% | -116% | -231% | |||
| Changes by quarters, q/q, % | -35% | +324% | -68% | -118% | +435% | |||